Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.56 |
| ▸ | DAO | P14920 | 1/20 | 0.49 |
| ▸ | DDO | Q99489 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | IAPP | P10997 | 2/20 | 0.46 |
| ▸ | CDK2 | P24941 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | SNCA | P37840 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3955098 | 0.86 | IDO1 (0.59) | GABRA1GABRB2IDO1GAA | |
| SCHEMBL3238496 | 0.85 | GABRA1 (0.57) | GABRA1GABRB2DAODDOCYP1A2 | |
| Ammonia Solution, Strong SCHEMBL28878772 | 0.85 | IDO1 (0.41) | GABRA1GABRB2DAODDOIDO1 | |
| SCHEMBL5545182 | 0.83 | IAPP (0.47) | GABRA1GABRB2IDO1IAPPCYP1A2 | |
| SCHEMBL26253878 | 0.81 | GABRA1 (0.54) | GABRA1GABRB2DAODDOTSHR | |
| SCHEMBL2987022 | 0.81 | LMNA (0.53) | IDO1CDK2CYP1A2HPGDHSD17B10 | |
| SCHEMBL3954604 | 0.81 | GABRA1 (0.50) | GABRA1GABRB2DAODDOIAPP | |
| SCHEMBL3593817 | 0.81 | GABRA1 (0.56) | GABRA1GABRB2DAODDOIAPP | |
| SCHEMBL3990467 | 0.81 | GABRA1 (0.56) | GABRA1GABRB2IDO1IAPPCDK2 | |
| SCHEMBL5540925 | 0.79 | BID (0.50) | IAPPHSD17B10MAPTALOX15KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024230707-A1 | QUINAZOLINE COMPOUND AND USE THEREOF | 上海医药集团股份有限公司 | 2024-11-14 | — | — | WO | disclosed |
| WO-2023061294-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 再鼎医药(上海)有限公司 | 2023-04-20 | — | — | WO | disclosed |
| CN-216024783-U | Continuous nitrosation reaction unit of beta naphthol | 九江善水科技股份有限公司 | 2022-03-15 | — | — | CN | disclosed |
| CN-110006833-A | A kind of analyzing detecting method of air amount of nitrogen oxides | 苏州华能检测技术有限公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-103097426-B | Epoxy compounds, solidification compound and cured article thereof | DIC CORP. (JP) | 2016-03-02 | — | — | CN | disclosed |
| EP-2816409-B1 | Method for forming a resist under layer film and patterning process | SHINETSU CHEMICAL CO (JP) | 2016-01-06 | — | — | EP | disclosed |
| CN-102532162-B | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMA CO LTD | 2015-05-27 | — | — | CN | disclosed |
| EP-2557103-B1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DAINIPPON INK & CHEMICALS (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8519065-B2 | Epoxy compound, curable composition, and cured product thereof | DIC CORPORATION (JP) | 2013-08-27 | — | — | US | disclosed |
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| CN-1798753-A | Process for producing phosphonitrilic acid ester | ASAHI CHEMICAL CORP (JP) | 2006-07-05 | — | — | CN | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| CN-1705670-A | 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds | OTSUKA PHARMA CO LTD (JP) | 2005-12-07 | — | — | CN | disclosed |
| US-20050250751-A1 | Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-11-10 | — | — | US | disclosed |
| WO-2005087225-A1 | NEO-TANSHINLACTONE AND ANALOGS AS POTENT AND SELECTIVE ANTI-BREAST CANCER AGENTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2005-09-22 | — | — | WO | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| US-6512006-B1 | Novel 3-position Nitrogen substituted 6,6- disubstituted-5, 6-dihydropyrones and related compounds possess antiviral properties | WARNER-LAMBERT COMPANY | 2003-01-28 | — | — | US | disclosed |
| US-5780571-A | RESIN OBTAINED BY CONDENSATION OF NAPHTHOL AND 4,4*-BIS/CHLOROMETHYL/BIPHENYL, OPTIONALLY REACTED WITH EPICHLOROHYDRIN | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1998-07-14 | — | — | US | disclosed |
| EP-0644216-B1 | NAPHTHALENE-RING RESIN, RESIN COMPOSITION, AND CURED PRODUCT THEREOF | NIPPON KAYAKU KK (JP) | 1996-07-17 | — | — | EP | disclosed |
| EP-0644216-A1 | NAPHTHALENE-RING RESIN, RESIN COMPOSITION, AND CURED PRODUCT THEREOF | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1995-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | GABRA1 692/4885GABRB2 554/4885DAO 1115/4885 |
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | HEATR1, EEF1A1, EPN1 | GABRA1 2594/4885GABRB2 3513/4885DAO 3251/4885 |
| US-20050250751-A1 | Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents | BRCA1, CYP19A1, CYP51A1 | GABRA1 3632/4885GABRB2 2150/4885DAO 4383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.